Literature DB >> 25406379

Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.

Viraj R Sanghvi1, Konstantinos J Mavrakis1, Joni Van der Meulen2, Michael Boice3, Andrew L Wolfe3, Mark Carty4, Prathibha Mohan1, Pieter Rondou5, Nicholas D Socci6, Yves Benoit7, Tom Taghon8, Pieter Van Vlierberghe5, Christina S Leslie9, Frank Speleman5, Hans-Guido Wendel10.   

Abstract

The posttranscriptional control of gene expression by microRNAs (miRNAs) is highly redundant, and compensatory effects limit the consequences of the inactivation of individual miRNAs. This implies that only a few miRNAs can function as effective tumor suppressors. It is also the basis of our strategy to define functionally relevant miRNA target genes that are not under redundant control by other miRNAs. We identified a functionally interconnected group of miRNAs that exhibited a reduced abundance in leukemia cells from patients with T cell acute lymphoblastic leukemia (T-ALL). To pinpoint relevant target genes, we applied a machine learning approach to eliminate genes that were subject to redundant miRNA-mediated control and to identify those genes that were exclusively targeted by tumor-suppressive miRNAs. This strategy revealed the convergence of a small group of tumor suppressor miRNAs on the Myb oncogene, as well as their effects on HBP1, which encodes a transcription factor. The expression of both genes was increased in T-ALL patient samples, and each gene promoted the progression of T-ALL in mice. Hence, our systematic analysis of tumor suppressor miRNA action identified a widespread mechanism of oncogene activation in T-ALL.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25406379      PMCID: PMC4693296          DOI: 10.1126/scisignal.2005500

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  56 in total

1.  An early decrease in Notch activation is required for human TCR-alphabeta lineage differentiation at the expense of TCR-gammadelta T cells.

Authors:  Inge Van de Walle; Greet De Smet; Magda De Smedt; Bart Vandekerckhove; Georges Leclercq; Jean Plum; Tom Taghon
Journal:  Blood       Date:  2008-12-03       Impact factor: 22.113

2.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

3.  Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.

Authors:  Teresa Palomero; Maria Luisa Sulis; Maria Cortina; Pedro J Real; Kelly Barnes; Maria Ciofani; Esther Caparros; Jean Buteau; Kristy Brown; Sherrie L Perkins; Govind Bhagat; Archana M Agarwal; Giuseppe Basso; Mireia Castillo; Satoru Nagase; Carlos Cordon-Cardo; Ramon Parsons; Juan Carlos Zúñiga-Pflücker; Maria Dominguez; Adolfo A Ferrando
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

4.  Tumorigenic activity and therapeutic inhibition of Rheb GTPase.

Authors:  Konstantinos J Mavrakis; Hong Zhu; Ricardo L A Silva; John R Mills; Julie Teruya-Feldstein; Scott W Lowe; Wayne Tam; Jerry Pelletier; Hans-Guido Wendel
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

5.  Widespread microRNA repression by Myc contributes to tumorigenesis.

Authors:  Tsung-Cheng Chang; Duonan Yu; Yun-Sil Lee; Erik A Wentzel; Dan E Arking; Kristin M West; Chi V Dang; Andrei Thomas-Tikhonenko; Joshua T Mendell
Journal:  Nat Genet       Date:  2007-12-09       Impact factor: 38.330

6.  Modelling Myc inhibition as a cancer therapy.

Authors:  Laura Soucek; Jonathan Whitfield; Carla P Martins; Andrew J Finch; Daniel J Murphy; Nicole M Sodir; Anthony N Karnezis; Lamorna Brown Swigart; Sergio Nasi; Gerard I Evan
Journal:  Nature       Date:  2008-08-17       Impact factor: 49.962

7.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Authors:  Changchun Xiao; Lakshmi Srinivasan; Dinis Pedro Calado; Heide Christine Patterson; Baochun Zhang; Jing Wang; Joel M Henderson; Jeffrey L Kutok; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

8.  High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA.

Authors:  Pieter Mestdagh; Tom Feys; Nathalie Bernard; Simone Guenther; Caifu Chen; Frank Speleman; Jo Vandesompele
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

9.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function.

Authors:  Michaela Scherr; Letizia Venturini; Karin Battmer; Michael Schaller-Schoenitz; Daniel Schaefer; Iris Dallmann; Arnold Ganser; Matthias Eder
Journal:  Nucleic Acids Res       Date:  2007-11-19       Impact factor: 16.971

10.  Most Caenorhabditis elegans microRNAs are individually not essential for development or viability.

Authors:  Eric A Miska; Ezequiel Alvarez-Saavedra; Allison L Abbott; Nelson C Lau; Andrew B Hellman; Shannon M McGonagle; David P Bartel; Victor R Ambros; H Robert Horvitz
Journal:  PLoS Genet       Date:  2007-12       Impact factor: 5.917

View more
  23 in total

Review 1.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

2.  Homeobox protein TLX3 activates miR-125b expression to promote T-cell acute lymphoblastic leukemia.

Authors:  Laurent Renou; Pierre-Yves Boelle; Caroline Deswarte; Salvatore Spicuglia; Aissa Benyoucef; Julien Calvo; Benjamin Uzan; Mohamed Belhocine; Agata Cieslak; Judith Landman-Parker; Andre Baruchel; Vahid Asnafi; Françoise Pflumio; Paola Ballerini; Irina Naguibneva
Journal:  Blood Adv       Date:  2017-05-04

Review 3.  Translating microRNAs into biomarkers: What is new for pediatric cancer?

Authors:  Ivna Néria Silva Ribamar de Carvalho; Renata Mendes de Freitas; Fernando Regla Vargas
Journal:  Med Oncol       Date:  2016-04-16       Impact factor: 3.064

Review 4.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

Review 5.  The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways.

Authors:  Emeline Bollaert; Audrey de Rocca Serra; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.261

6.  AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival.

Authors:  Rigel J Kishton; Carson E Barnes; Amanda G Nichols; Sivan Cohen; Valerie A Gerriets; Peter J Siska; Andrew N Macintyre; Pankuri Goraksha-Hicks; Aguirre A de Cubas; Tingyu Liu; Marc O Warmoes; E Dale Abel; Allen Eng Juh Yeoh; Timothy R Gershon; W Kimryn Rathmell; Kristy L Richards; Jason W Locasale; Jeffrey C Rathmell
Journal:  Cell Metab       Date:  2016-04-12       Impact factor: 27.287

Review 7.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

8.  Myb drives B-cell neoplasms and myeloid malignancies in vivo.

Authors:  Tim Pieters; André Almeida; Sara T'Sas; Kelly Lemeire; Tino Hochepied; Geert Berx; Alex Kentsis; Steven Goossens; Pieter Van Vlierberghe
Journal:  Blood Adv       Date:  2022-05-24

9.  c-Myb Binding Sites in Haematopoietic Chromatin Landscapes.

Authors:  Mads Bengtsen; Kjetil Klepper; Sveinung Gundersen; Ignacio Cuervo; Finn Drabløs; Eivind Hovig; Geir Kjetil Sandve; Odd Stokke Gabrielsen; Ragnhild Eskeland
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

Review 10.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.